Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Ependymoma 1Craniopharyngioma 1

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Biopsy 4ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2LY3023414 2Filgrastim 2trametinib 1sonidegib 1sargramostim 1ribociclib 1entinostat 1dostarlimab 1carboxyamido-triazole 1bempegaldesleukin 1Thalidomide 1Pharmacogenomic Variants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ependymoma × Methionine × Lymphoid × Clear all
NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡